Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Barinthus Biotherapeutics (BRNS) Other Non Operating Income (2020 - 2026)

Barinthus Biotherapeutics filings provide 7 years of Other Non Operating Income readings, the most recent being $39000.0 for Q1 2026.

  • On a quarterly basis, Other Non Operating Income fell 48.0% to $39000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was -$20000.0, a 109.52% decrease, with the full-year FY2025 number at $16000.0, down 88.15% from a year prior.
  • Other Non Operating Income hit $39000.0 in Q1 2026 for Barinthus Biotherapeutics, up from -$104000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $13.8 million in Q1 2022 to a low of -$275000.0 in Q3 2025.
  • Median Other Non Operating Income over the past 5 years was $63000.0 (2022), compared with a mean of $1.1 million.
  • Biggest five-year swings in Other Non Operating Income: skyrocketed 1800.0% in 2022 and later tumbled 1157.69% in 2025.
  • Barinthus Biotherapeutics' Other Non Operating Income stood at $516000.0 in 2022, then soared by 50.0% to $774000.0 in 2023, then crashed by 88.5% to $89000.0 in 2024, then plummeted by 216.85% to -$104000.0 in 2025, then soared by 137.5% to $39000.0 in 2026.
  • The last three reported values for Other Non Operating Income were $39000.0 (Q1 2026), -$104000.0 (Q4 2025), and -$275000.0 (Q3 2025) per Business Quant data.